Upon conclusion of this program, participants should be able to:

• Describe the results of important disease-specific clinical trials presented at the American Society of the 2011 Hematology annual meeting.
• Identify investigational therapeutic regimens that are available as alternatives to standard of care approaches.
• Compare with current clinical practice the advances in managing various hematological malignancies that were presented at the American Society of Hematology annual meeting.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.